A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.

OBJECTIVES: To assess the efficacy and safety of adefovir dipivoxil (ADV) added to stable background antiretroviral therapy (ART) in HIV-infected individuals with advanced HIV disease. METHODS: ADHOC was a randomized, double-blind, placebo-controlled, international multicentre trial. Three hundred...

Description complète

Détails bibliographiques
Auteur principal: ADHOC International Steering Committee
Format: Journal article
Langue:English
Publié: 2002

Documents similaires